Showing results (51-60 of 160) with videos related to
Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2022
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive ScoreBarbara Burtness, Danny Rischin, Richard Greil, et al.American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trialAthanassios Argiris, Musie Ghebremichael, Jill Gilbert, et al.International Journal of Radiation Oncology, Biology, Physics|April 14, 2010
Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancerAruna Turaka, Tianyu Li, Nicos Nicolaou, et al.International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancerLawrence Kleinberg, Jonathan P S Knisely, Richard Heitmiller, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinomaEirini Pectasides, Theodore Rampias, Panteleimon Kountourakis, et al.Plos One|April 12, 2014
Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC)Eirini Pectasides, Theodoros Rampias, Clarence Sasaki, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 20, 2020
Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and NeckDaniel Jacobs, Kelly Olino, Henry S Park, et al.European Journal of Cancer (Oxford, England : 1990)|January 12, 2024
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305Athanassios Argiris, Yael Flamand, Panayiotis Savvides, et al.Head & Neck|September 20, 2011
Nonsurgical management of oropharyngeal, laryngeal, and hypopharyngeal cancer: the Fox Chase Cancer Center experienceGenevieve Andrews, Miriam Lango, Roger Cohen, et al.Pageof 16